MCIM
BIIB icon

Meadow Creek Investment Management’s Biogen BIIB Stock Holding History

Meadow Creek Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$11.4M Sell
48,796
-8,338
-15% -$1.94M 0.22% 84
2019
Q2 		$13.4M Sell
57,134
-17,424
-23% -$4.02M 0.27% 80
2019
Q1 		$17.6M Buy
74,558
+16,588
+29% +$5.22M 0.36% 66
2018
Q4 		$17.4M Sell
57,970
-4,158
-7% -$1.33M 0.41% 56
2018
Q3 		$22M Sell
62,128
-3,960
-6% -$1.36M 0.43% 50
2018
Q2 		$19.2M Buy
66,088
+8,096
+14% +$2.28M 0.41% 58
2018
Q1 		$15.9M Buy
57,992
+27,984
+93% +$8.69M 0.34% 67
2017
Q4 		$9.56M Buy
30,008
+11,220
+60% +$3.6M 0.21% 105
2017
Q3 		$5.88M Buy
18,788
+3,674
+24% +$1.09M 0.14% 146
2017
Q2 		$4.1M Buy
15,114
+7,458
+97% +$1.97M 0.1% 186
2017
Q1 		$2.09M Buy
7,656
+5,192
+211% +$1.47M 0.05% 286
2016
Q4 		$699K Buy
+2,464
New +$730K 0.02% 438

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Meadow Creek Investment Management's BIIB Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Biogen (BIIB) stake by 15% in Q3 2019, selling an estimated $1.94M and leaving 48,796 shares worth $11.4M. The position accounts for 0.22% of the portfolio, ranked #84.

Meadow Creek Investment Management first reported a position in BIIB in Q4 2016 and has held it in 12 quarters since. The position peaked at $22M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Meadow Creek Investment Management held 48,796 shares of Biogen worth $11.4M as of Q3 2019.
  • Meadow Creek Investment Management sold 8,338 Biogen shares in Q3 2019, an estimated $1.94M.
  • Biogen made up 0.22% of Meadow Creek Investment Management's portfolio in Q3 2019, its #84 holding.
  • Meadow Creek Investment Management first reported a position in Biogen in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Biogen position peaked at $22M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.